Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer

MLA

Hiroyuki Sayama, et al. “Virtual Clinical Trial Simulations for a Novel KRASG12C Inhibitor (ASP2453) in Non‐small Cell Lung Cancer.” CPT: Pharmacometrics & Systems Pharmacology, vol. 10, no. 8, Aug. 2021, pp. 864–77. EBSCOhost, https://doi.org/10.1002/psp4.12661.

APA

Hiroyuki Sayama, Diana Marcantonio, Takeyuki Nagashima, Masashi Shimazaki, Tsuyoshi Minematsu, Joshua F Apgar, John M. Burke, Lucia Wille, Yasuhisa Nagasaka, & Daniel C. Kirouac. (2021). Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer. CPT: Pharmacometrics & Systems Pharmacology, 10(8), 864–877. https://doi.org/10.1002/psp4.12661

Chicago

Hiroyuki Sayama, Diana Marcantonio, Takeyuki Nagashima, Masashi Shimazaki, Tsuyoshi Minematsu, Joshua F Apgar, John M. Burke, Lucia Wille, Yasuhisa Nagasaka, and Daniel C. Kirouac. 2021. “Virtual Clinical Trial Simulations for a Novel KRASG12C Inhibitor (ASP2453) in Non‐small Cell Lung Cancer.” CPT: Pharmacometrics & Systems Pharmacology 10 (8): 864–77. doi:10.1002/psp4.12661.